Efficacy, Safety, and Tolerability of Laquinimod in Relapsing Remitting Multiple Sclerosis

Study Title

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Teva Identifier

LAQ-MS-305 | 2012-003647-30

ClinicalTrials.gov Identifier

NCT01707992

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Drug: Laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

February 20, 2013 - July 4, 2017

Phase

Phase 3

Study Type

Interventional